Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Myasthenia Gravis × telitacicept × Clear all

Phase

Phase 3 3 Phase NA 2 Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1 Autoimmune Diseases 1

Interventions

Pyridostigmine Bromide 2 Prednisone 2 telitacicept 1 rozanolixizumab 1 ravulizumab 1 efgartigimod alfa 1 Prednisolone 1 Immunoglobulins, Intravenous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06723548 2024-12-09

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

First Affiliated Hospital of Wenzhou Medical University

Phase 4 Not yet recruiting

Autoimmune Diseases, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡